Summary
NF-κB plays a pivotal role in immunity and inflammation and is considered to be a promising candidate for drug development. However, global suppression of NF-κB may have undesirable side-effects. Our data and the results of others suggest that each of the five NF-κB subunits may have a specific function in controlling the expression of inflammatory mediators in immune cells. Identifying the role for each NF-κB subunit in primary human immune cells will allow a more targeted approach to inhibiting NF-κB subunit-specific cellular functions. However, results obtained with primary human cells can often be inconsistent due to donor heterogeneity. Therefore one possible approach could be to generate human immune cell lines with stably inhibited expression of specific NF-κB subunit(s) as described in this chapter.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Handel, M.L., McMorrow, L.B. and Grav-allese, E.M. (1995) Nuclear factor-kappa B in rheumatoid synovium. Localisation of p50 and p65. Arthritis Rheum 38, 1762–1770.
Feldmann, M., Andreakos, E., Smith, C., Bondeson, J., Yoshimura, S., Kiriakidis, S., Monaco, C., Gasparini, C., Sacre, S., Lund-berg, A., et al. (2002) Is NF-kappaB a useful therapeutic target in rheumatoid arthritis? Ann Rheum Dis 61 Suppl 2, ii13–ii18.
Karin, M., Yamamoto, Y. and Wang, Q.M. (2004) The IKK NF-kappaB system: a treasure trove for drug development. Nat Rev Drug Discov 3, 17–26.
Natoli, G. (2006) Tuning up inflammation: how DNA sequence and chromatin organisation control the induction of inflammatory genes by NF-kappaB. FEBS Lett 580, 2843–2849.
Beg, A.A., Sha, W.C., Bronson, R.T., Ghosh, S. and Baltimore, D. (1995) Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature 376, 167–170.
Dykxhoorn, D.M., Novina, C.D. and Sharp, P.A. (2003) Killing the messenger: short RNAs that silence gene expression. Nat Rev Mol Cell Biol 4, 457–467.
Hoffmann, A., Leung, T.H. and Baltimore, D. (2003) Genetic analysis of NF-kappaB/Rel transcription factors defines functional specificities. EMBO J 22, 5530–5539.
Naldini, L., Blomer, U., Gallay, P., Ory, D., Mulligan, R., Gage, F.H., Verma, I.M. and Trono, D. (1996) In vivo gene delivery and stable transduction of non-dividing cells by a lentiviral vector. Science 272, 263–267.
Ziegler-Heitbrock, H.W., Thiel, E., Futterer, A., Herzog, V., Wirtz, A. and Riethmuller, G. (1988) Establishment of a human cell line (Mono Mac 6) with characteristics of mature monocytes. Int J Cancer 41, 456–461.
Davis, H.E., Rosinski, M., Morgan, J.R. and Yarmush, M.L. (2004) Charged polymers modulate retrovirus transduction via membrane charge neutralisation and virus aggregation. Biophys J 86, 1234–1242.
Acknowledgments
We would like to thank Drs Nicole Horwood and Bernard Gregory (Kennedy Institute) for providing us with the GATEWAY compatible pENTRY-U6 and pLenti_LV5 vectors. This work was supported by the MRC New Investigator Award #75548 to IU.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Humana Press, a part of Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Goh, F.G., Banks, H., Udalova, I.A. (2009). Detecting and Modulating the NF-kB Activity in Human Immune Cells: Generation of Human Cell Lines with Altered Levels of NF-κB. In: Kozlov, S.V. (eds) Inflammation and Cancer. Methods in Molecular Biology™, vol 512. Humana Press. https://doi.org/10.1007/978-1-60327-530-9_4
Download citation
DOI: https://doi.org/10.1007/978-1-60327-530-9_4
Publisher Name: Humana Press
Print ISBN: 978-1-60327-529-3
Online ISBN: 978-1-60327-530-9
eBook Packages: Springer Protocols